Skip to main content
TipRanks
Go Ultimate75% OFF

Glenmark Pharmaceuticals Limited (GLENMARK) Ratios

5 Followers

Glenmark Pharmaceuticals Limited Ratios

IN:GLENMARK's free cash flow for Q4 2026 was ₹0.00. For the 2026 fiscal year, IN:GLENMARK's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio1.771.561.282.101.77
Quick Ratio1.231.010.841.641.23
Cash Ratio0.180.290.280.230.30
Solvency Ratio0.210.18-0.170.060.13
Operating Cash Flow Ratio0.52-0.14-0.050.120.24
Short-Term Operating Cash Flow Coverage0.00-0.49-0.271.261.01
Net Current Asset Value₹ 19.04B₹ 20.95B₹ 9.17B₹ 11.93B₹ 6.37B
Leverage Ratios
Debt-to-Assets Ratio0.030.150.090.240.23
Debt-to-Equity Ratio0.060.280.160.490.44
Debt-to-Capital Ratio0.050.220.140.330.30
Long-Term Debt-to-Capital Ratio0.000.050.000.290.22
Financial Leverage Ratio1.891.811.832.041.88
Debt Service Coverage Ratio10.270.96-0.031.301.05
Interest Coverage Ratio19.1620.206.588.0511.94
Debt to Market Cap0.000.050.040.330.29
Interest Debt Per Share28.4394.9661.91175.67150.96
Net Debt to EBITDA-0.210.35-0.232.411.33
Profitability Margins
Gross Profit Margin47.60%66.14%63.79%62.16%63.04%
EBIT Margin12.92%14.27%11.43%9.76%14.95%
EBITDA Margin16.29%16.22%14.47%12.26%15.54%
Operating Profit Margin23.55%31.31%26.84%24.12%28.94%
Pretax Profit Margin11.69%10.47%0.29%2.06%11.71%
Net Profit Margin8.02%7.84%-11.88%2.55%7.65%
Continuous Operations Profit Margin8.02%7.84%-14.48%-0.77%8.08%
Net Income Per EBT68.62%74.83%-4114.72%123.93%65.34%
EBT Per EBIT49.63%33.44%1.08%8.53%40.48%
Return on Assets (ROA)6.84%6.52%-10.46%1.53%5.51%
Return on Equity (ROE)12.96%11.83%-19.13%3.14%10.36%
Return on Capital Employed (ROCE)29.55%41.50%39.74%19.71%28.73%
Return on Invested Capital (ROIC)20.12%26.41%-1770.16%-7.07%18.07%
Return on Tangible Assets7.83%7.18%-11.53%1.75%6.36%
Earnings Yield2.26%2.46%-5.42%2.27%7.55%
Efficiency Ratios
Receivables Turnover3.423.206.803.593.97
Payables Turnover2.381.751.812.201.99
Inventory Turnover2.591.381.821.861.82
Fixed Asset Turnover3.933.463.572.762.64
Asset Turnover0.850.830.880.600.72
Working Capital Turnover Ratio4.125.413.502.533.65
Cash Conversion Cycle93.83170.8051.82132.55108.94
Days of Sales Outstanding106.68114.2053.64101.6691.99
Days of Inventory Outstanding140.72264.67200.32196.42200.62
Days of Payables Outstanding153.56208.07202.15165.54183.67
Operating Cycle247.40378.87253.97298.08292.61
Cash Flow Ratios
Operating Cash Flow Per Share116.91-29.33-9.4122.1639.29
Free Cash Flow Per Share68.80-55.89-41.250.6211.29
Dividend Paid and CapEx Coverage Ratio2.20-1.01-0.260.841.26
Capital Expenditure Coverage Ratio2.43-1.10-0.301.031.40
Operating Cash Flow Coverage Ratio5.56-0.33-0.220.140.28
Operating Cash Flow to Sales Ratio0.19-0.06-0.020.050.09
Free Cash Flow Yield3.23%-3.70%-4.20%0.13%2.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio44.1740.67-18.4644.1113.25
Price-to-Sales (P/S) Ratio3.543.192.191.121.01
Price-to-Book (P/B) Ratio5.724.813.531.381.37
Price-to-Free Cash Flow (P/FCF) Ratio30.98-27.00-23.82743.7939.16
Price-to-Operating Cash Flow Ratio18.23-51.46-104.4420.9711.25
Price-to-Earnings Growth (PEG) Ratio1.47-0.26-0.02-0.37-4.51
Enterprise Value Multiple21.5320.0014.9211.597.86
Enterprise Value595.72B433.55B272.95B165.61B150.25B
EV to EBITDA21.5320.0014.9211.597.86
EV to Sales3.513.242.161.421.22
EV to Free Cash Flow30.68-27.49-23.45939.4247.17
EV to Operating Cash Flow18.06-52.39-102.8326.4813.55
Tangible Book Value Per Share283.69261.84230.82263.07253.46
Shareholders’ Equity Per Share372.52313.60278.13335.75321.99
Tax and Other Ratios
Effective Tax Rate0.310.2551.171.370.31
Revenue Per Share601.81473.56448.15413.07436.03
Net Income Per Share48.2637.11-53.2210.5333.37
Tax Burden0.690.75-41.151.240.65
Interest Burden0.900.730.030.210.78
Research & Development to Revenue0.000.070.100.110.10
SG&A to Revenue0.240.280.230.230.20
Stock-Based Compensation to Revenue0.00-0.000.000.000.00
Income Quality2.42-0.590.180.720.77

Currency in INR